En español
NIDA

Tobacco/Nicotine

References

  1. Adams, E.K.; Miller, V.P.; Ernst, C.; Nishimura, B.K.; Melvin, C.; and Merritt, R. Neonatal health care costs related to smoking during pregnancy. Health Economics 11:193–206, 2002.
  2. Belluzzi, J.D.; Wang, R.; and Leslie, F.M. Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacol 30:705–712, 2005.
  3. Benowitz, N.L. Pharmacology of nicotine: Addiction and therapeutics. Ann Rev Pharmacol Toxicol 36:597–613, 1996.
  4. Breslau, N., and Johnson, E.O. Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health 90(7):1122–1127, 2000.
  5. Buka, S.L.; Shenassa, E.D.; and Niaura, R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: A 30-year prospective study. Am J Psychiatry 160:1978–1984, 2003.
  6. Covey, L.S.; Glassman, A.H.; and Stetner, F. Major depression following smoking cessation. Am J Psychiatry 154:263–265, 1997.
  7. Dervaux, A., and Laqueille, X. Smoking and schizophrenia: Epidemiological and clinical features. Encephale 34(3):299–305, 2008.
  8. Ernst, M.; Moolchan, E.T.; and Robinson, M.L. Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40:630–641, 2001.
  9. Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Pappas, N.; Logan, J.; MacGregor, R.; Alexoff, D.; Shea, C.; Schlyer, D.; Wolf, A.P.; Warner, D.; Zezulkova, I.; and Cilento, R. Inhibition of monoamine oxidase B in the brains of smokers. Nature 22:733–736, 1996.
  10. Hatsukami, D.K.; Lemmonds, C.; Zhang, Y.; Murphy, S.E.; Le, C.; Carmella, S.G.; and Hecht, S.S. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. J Natl Cancer Inst 96:844–852, 2004.
  11. Henningfield, J.E. Nicotine medications for smoking cessation. New Engl J Med 333:1196–1203, 1995.
  12. Johnston, L.D.; O’Malley, P.M.; Bachman, J.G.; and Schulenberg, J.E. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2011. NIH Pub. No. 11–6418. Bethesda, MD: National Institute on Drug Abuse, 2011. Available at: www.monitoringthefuture.org.
  13. Ilomäki, R., et al. Temporal association of onset of daily smoking with adolescent substance use and psychiatric morbidity. Eur Psychiatry 23(2):85–91, 2008.
  14. John, U.; Meyer, C.; Rumpf, H.J.; and Hapke, U. Smoking, nicotine dependence and psychiatric comorbidity: A population-based study including smoking cessation after three years. Drug Alcohol Depend 76:287–295, 2004.
  15. Kalman, D.; Morissette, S.B.; and George, T.P. Comorbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14(2):106–123, 2005.
  16. Kollins, S.H.; McClernon, F.J.; and Fuemmeler, B.F. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry 62:1142–1147, 2005.
  17. Levin, E.D.; Rezvani, A.H.; Montoya, D.; Rose, J.E.; and Swartzwelder, H.S. Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacol 169:141–149, 2003.
  18. Morissette, S.B.; Tull, M.T.; Gulliver, S.B.; Kamholz, B.W.; and Zimering, R.T. Anxiety, anxiety disorders, tobacco use, and nicotine: A critical review of interrelationships. Psychol Bull 133(2):245–272, 2007.
  19. Perkins, K.A.; Donny, E.; and Caggiula, A.R. Sex differences in nicotine effects and self–administration: Review of human and animal evidence. Nic and Tobacco Res 1:301–315, 1999.
  20. Saccone, S.F., et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16(1):36–49, 2007.
  21. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No. SMA 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011. Available at http://oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.htm.
  22. Thorgeirsson, T.E., et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452(7187):638–642, 2008.
  23. U.S. Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2000. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/index.htm.
  24. U.S. Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/index.htm.
  25. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/index.htm.

This page was last updated July 2012

Get this Publication

​Research Reports

This series of reports simplifies the science of research findings for the educated lay public, legislators, educational groups, and practitioners. The series reports on research findings of national interest.